Graphium Biosciences logo

Graphium Biosciences Employee Directory

Biotechnology ResearchCalifornia, United States2-10 Employees

Graphium Biosciences, located in Los Angeles, California, operates as a wholly owned subsidiary of Malachite Innovations and concentrates on developing pharmaceutical-grade cannabinoid therapies for inflammatory bowel disease. Its approach centers on a glycosylation process that bonds glucose to cannabinoids, creating glycosylated compounds intended to rebalance the endocannabinoid system and reduce GI inflammation without producing psychoactive effects. The firm's leading compound, VBX-100, is a glycosylated THC variant that has received FDA Orphan Drug Designation for pediatric ulcerative colitis. The company has developed a portfolio of over 250 glycosylated cannabinoids and endocannabinoids, with patent coverage backing these candidates. This positioning places Graphium within the wider field of targeted IBD therapeutics. Based in a small team setting, Graphium outlines a plan to advance VBX-100 through the remaining animal studies and early-stage clinical testing over a three-year period.

Find Graphium Biosciences employees' phone numbers or email addresses

Graphium Biosciences Global Highlights

Location
Employees

North America
4

Minus sign iconPlus sign icon
  • United States Of America
    4

Europe
1

Minus sign iconPlus sign icon
  • France
    1

Graphium Biosciences's Leadership

  • Chief Financial Officer at Graphium Biosciences
    R. M.
    Chief Financial Officer
  • Controller at Graphium Biosciences
    M. M.
    Controller
  • Research Scientist at Graphium Biosciences
    E. S.
    Research Scientist

Graphium Biosciences Employee Metrics

100%
50%
0%
2026
2025
  • Biotechnology
  • Business
  • Administrative
  • Sales
  • Accounting
  • Other
  • Analytics

Contact profiles from Graphium Biosciences

Name
Title
Contact
Location
Last Update
  • Chief Financial Officer at Graphium Biosciences
    R. M.
    Chief Financial Officer
    France, Île-de-France
    Jun 24, 2026
  • Controller at Graphium Biosciences
    M. M.
    Controller
    Oct 21, 2024
  • Research Scientist at Graphium Biosciences
    E. S.
    Research Scientist
    Oct 18, 2024

Frequently Asked Questions

What is Graphium Biosciences known for?

Minus sign iconPlus sign icon
Graphium Biosciences was founded in 2012 and operates in the Biotechnology Research industry. You can contact Graphium Biosciences's main corporate office by phone at . Explore Graphium Biosciences's company overview page for more information.

What is Graphium Biosciences's most common email format?

Minus sign iconPlus sign icon
Graphium Biosciences employees' email format typically follows the pattern of Last@vitality.bio. Trying to find reliable and up-to-date employee contact data? Find more Graphium Biosciences email formats with LeadIQ.

How many employees does Graphium Biosciences have currently?

Minus sign iconPlus sign icon
Graphium Biosciences has approximately 3 employees as of August 2026. These team members are located across 2 continents, including North America and Europe.

Who are Graphium Biosciences's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Graphium Biosciences's key employees include:

  • Chief Financial Officer: R. M.
  • Controller: M. M.
  • Research Scientist: E. S.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.